These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18058029)

  • 1. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
    McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
    Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
    Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
    Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma.
    Novak M; Jarrett SG; McCorkle JR; Mellon I; Kaetzel DM
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):433-8. PubMed ID: 21448569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
    Ouatas T; Halverson D; Steeg PS
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis.
    Mátyási B; Farkas Z; Kopper L; Sebestyén A; Boissan M; Mehta A; Takács-Vellai K
    Pathol Oncol Res; 2020 Jan; 26(1):49-61. PubMed ID: 31993913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
    MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
    J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
    Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
    Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
    Leone A; Flatow U; VanHoutte K; Steeg PS
    Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.
    Marino N; Marshall JC; Steeg PS
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):351-62. PubMed ID: 21713383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations at the dimer interface and surface residues of Nm23-H1 metastasis suppressor affect its expression and function.
    Li Y; Liu W; Saini V; Wong YH
    Mol Cell Biochem; 2020 Nov; 474(1-2):95-112. PubMed ID: 32705629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
    Khan MH; Yasuda M; Higashino F; Haque S; Kohgo T; Nakamura M; Shindoh M
    Am J Pathol; 2001 May; 158(5):1785-91. PubMed ID: 11337376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nm23 and tumour metastasis: basic and translational advances.
    Freije JM; MacDonald NJ; Steeg PS
    Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
    Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
    Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
    Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
    Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
    Lee HY; Lee H
    Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.